Paratek Pharmaceuticals, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 876-900 of 958 matching filings.

Per page

25

Current page

36

4

OPTION MODIFICATION 2011

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OPTION AMENDMENTS 2011

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 03 Feb 2011
Reporting date: 02 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-172041

FORM S-8

Filing date: 03 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 31 Jan 2011
Reporting date: 31 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 28 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

2011 ANNUAL GRANT

Filing date: 27 Jan 2011
Reporting date: 27 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 26 Jan 2011
Reporting date: 26 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 24 Jan 2011
Reporting date: 21 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 18 Jan 2011
Reporting date: 18 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

WORTZMAN 10B5 EXERCISE AND SALE

Filing date: 10 Jan 2011
Reporting date: 07 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 10 Jan 2011
Reporting date: 10 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51967

FORM 8-K

Filing date: 06 Jan 2011
Reporting date: 05 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .